Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
16.52
-0.94 (-5.38%)
At close: Sep 23, 2026, 4:00 PM EDT
16.66
+0.14 (0.85%)
After-hours: Sep 23, 2026, 6:23 PM EDT
Generate Biomedicines Revenue
Generate Biomedicines had revenue of $6.31M in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $26.48M. In the year 2025, Generate Biomedicines had annual revenue of $31.89M with 55.89% growth.
Revenue (ttm)
$26.48M
Revenue Growth
+55.89%
P/S Ratio
80.21
Revenue / Employee
$84,881
Employees
312
Market Cap
2.12B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 31.89M | 11.43M | 55.89% |
| Dec 31, 2024 | 20.46M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
GENB News
- 10 hours ago - Generate Biomedicines Transcript: Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum - Transcripts
- 7 days ago - Generate Biomedicines Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 9 days ago - Generate Biomedicines Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 14 days ago - Generate Biomedicines Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 15 days ago - Generate Biomedicines Inc. to Participate in September Investor Conferences - GlobeNewsWire
- 26 days ago - Generate Biomedicines price target raised to $30 from $25 at H.C. Wainwright - TheFly
- 4 weeks ago - Generate Biomedicines falls -16.7% - TheFly
- 4 weeks ago - Generate Biomedicines falls -11.0% - TheFly